or
forgot password

Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer


N/A
35 Years
80 Years
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer


Inclusion Criteria:



1. Male, 35-80 years old

2. Patients who present for a routine check-up

3. Patients who present for the evaluation of an abnormal exam or test (elevated PSA,
abnormal DRE, etc.)

4. Patients who present for the evaluation of a palpable nodule or induration on
prostate exam

5. Patients may present with a biopsy proven prostate cancer from outside physician for
inclusion into arms 2 or 3

6. For group 1 a negative prostate biopsy

Exclusion Criteria:

1. Patient < 35 or > 81 years of age

2. Concurrent eye infection or trauma

3. Active conjunctivitis

4. Abnormal production of tears (too much or too little)

5. Any other conditions the PI or staff feels will not fulfill the criteria for study
entry or will place the subject in a harmful environment

6. Atypia on prostate biopsy report

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Cross-Sectional

Principal Investigator

Matthew D Katz, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Arkansas

Authority:

United States: Institutional Review Board

Study ID:

133719

NCT ID:

NCT01514669

Start Date:

January 2012

Completion Date:

Related Keywords:

  • Prostate Cancer
  • Prostatic Neoplasms

Name

Location

University of Arkansas for Medical Sciences Little Rock, Arkansas  72205